Stocks and Investing Stocks and Investing
Thu, March 30, 2017
Wed, March 29, 2017

Do Kim Upgraded (VRTX) to Buy on, Mar 29th, 2017


Published on 2024-10-25 20:39:04 - WOPRAI, Do Kim
  Print publication without navigation


Do Kim of BMO Capital, Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Buy on, Mar 29th, 2017.

Do has made no other calls on VRTX in the last 4 months.



There are 3 other peers that have a rating on VRTX. Out of the 3 peers that are also analyzing VRTX, 2 agree with Do's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Hartaj Singh of "Oppenheimer" Initiated at Hold on, Thursday, December 15th, 2016
  • Geoff Meacham of "Barclays" Downgraded from Buy to Hold on, Tuesday, November 29th, 2016


This is the rating of the analyst that currently disagrees with Do


  • Liisa Bayko of "JMP Securities" Upgraded from Hold to Buy on, Friday, March 17th, 2017

Contributing Sources